Walleye Trading LLC Cure Vac N.V. Call Options Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 08, 2022	BUY	$13.18 - $19.41 $274,144 - $403,728	20,800 Added 208.0%	30,800 $419,000
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $114,894 - $274,950	7,800 Added 354.55%	10,000 $196,000
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $809,280 - $1.16 Million	-24,000 Reduced 91.6%	2,200 $75,000
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $733,974 - $1.11 Million	14,900 Added 131.86%	26,200 $1.43 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $512,189 - $1.15 Million	9,000 Added 391.3%	11,300 $830,000
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $183,517 - $290,467	2,300 New	2,300 $210,000

12.6M

68.1K

55.7K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $684M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.